Search Results 1341-1350 of 19034 for Neutrophil

1. Fecal calprotectin assay performs well as biomarker for measurement of ulcerative colitis disease activity - Mayo Clinic

   Calprotectin is a protein released by activated neutrophils during inflammation. Dr. Loftus and colleagues have reviewed the published literature examining ...

2. The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach - Mayo Clinic

   Positive anti-neutrophil cytoplasmic antibody (ANCA) test specific for proteinase-3 measures by enzyme-linked immunoassay. Patients who are myeloperoxidase ...

3. A Study of LOXO-292 in Patients with Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1.0 × 109/L not requiring growth factor support for at least 7 days prior to treatment, and; Platelet count ≥ 75 × 109/L ...

4. A Study to Evaluate Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients with Germ Cell Tumors - Mayo Clinic

   Peripheral absolute neutrophil count (ANC) ≥ 1,000/mm^3. Platelet count ≥ 100,000/mm^3. Patients enrolling on the standard risk arms must be medically fit ...

5. Turkey Tail Mushroom For Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery - Mayo Clinic

   * Absolute neutrophil count (ANC) ≥ 1,000/mm^3 (obtained ≤ 90 days prior to registration) * Hemoglobin ≥ 11 g/dL (obtained ≤ 90 days prior to ...

6. Phase I Study Of BL0020, A Novel Anti-tumor Drug, In Adult Subjects With Advanced Solid Tumors - Mayo Clinic

   * Absolute Neutrophil Count (ANC) \< 1.5×109/L. * Total bilirubin \> 1.5×ULN. * Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) \> 3×ULN ...

7. MC230813 A Study of Golcadomide with Rituximab prior to CAR-T with Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1000/mcL; growth factor support allowed at physician discretion. Platelet count ≥75,000/mcL; Total bilirubin ≤1.5 x ULN ...

8. Investigational Trial To Evaluate XC001 Delivered Via An Cardiac Catheter In Subjects With Chronic Angina. - Mayo Clinic

   Body mass index \> 45 kg/m2. 5. Hemoglobin \< 10 g/dL, absolute neutrophil count \< 1.2 × 103 per µL, platelet count \< 75,000 per µL, alanine ...

9. Study Of Chemotherapy Plus Ipatasertib For People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial - Mayo Clinic

   - Absolute neutrophil count >= 1.5 x 10^3/uL (within 28 days prior to registration) - Platelets >= 100 x 10^3/uL (within 28 days prior to registration)

10. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial - Mayo Clinic

    evaluation. - Leukocytes >= 3,000/mcL (obtained =< 14 days prior to protocol randomization) - Absolute neutrophil count (ANC) >= 1,500/mcL (obtained =< 14 ...